Skip to Navigation
Cardiff and Vale University Health Board
Time period: 2020-2022
|
Organisation |
|
National |
Number of oesophago-gastric (OG) cancer patients in audit |
157 |
|
19,865 |
Case ascertainment for OG cancer (%) |
85-100% |
|
|
Method of Diagnosis |
– Patients diagnosed after an emergency admission** ** Percent figure accounts for differences in mix of patients across organisations |
28 |
21.6% |
13.1% |
– Patients with referral source reported as unknown |
7 |
4.5% |
1.4% |
Pre-treatment staging of cancer |
– Patients having staging CT scan recorded |
144 |
91.7% |
94.0% |
Treatment planning |
– Patients having a plan for curative treatment |
77 |
49.0% |
37.2% |
– Patients having a plan for non-curative treatment |
80 |
51.0% |
62.8% |
– Patients with non-curative plans having chemotherapy or radiotherapy |
32 |
40.0% |
34.7% |
Time period: 2019-2022
|
Organisation |
National |
Number of patients having surgery |
136 |
5452 |
Length of stay, median (days) |
13 |
10 |
Operations in which 15 or more lymph nodes were examined (%) |
93.1% |
90.1% |
30-day postoperative mortality (%) |
1.8% |
1.5% |
90-day postoperative mortality (%) |
1.8% |
2.9% |
Oesophageal surgery |
Number of patients having oesophageal surgery |
91 |
N/A |
Oesophageal patients with positive longitudinal margins (%) |
11.3% |
4.9% |
Oesophageal patients with positive circumferential margins (%) |
34.2% |
21.5% |
Gastric surgery |
Number of patients having gastric surgery |
45 |
N/A |
Gastric patients with positive longitudinal margins (%) |
5.0% |
9.8% |
Compare trust outcomes
Download this data as a PDF
Copyright © 2024 National Oesophago-Gastric Cancer Audit | Lovingly Crafted by
Mixd